Literature DB >> 11806137

The relationship between poliovirus multiplication, the sIgA antibody response and the serum neutralizing antibody titers after trivalent oral polio vaccination.

N Morimoto1.   

Abstract

The time kinetics of poliovirus and secretory IgA (sIgA) antibody titers were examined in fecal samples from four vaccinees immunized with two doses of trivalent oral polio vaccine (TOPV) from 1996 to 2000. Poliovirus types 1 and 2 multiplied in the human intestine after the first vaccination, and poliovirus type 3 multiplied after the second vaccination. Additionally, poliovirus type 3 multiplied for several days in two cases after the first vaccination, and poliovirus types 1 and 2 multiplied for before and after a week in one case after the second vaccination. Poliovirus type 2 multiplied most efficiently in the human intestine and stimulated the sIgA antibody response. The sIgA antibody titers are required to be > or = 1:4 for poliovirus types 1 and 3, and > or = 1:8 for poliovirus type 2 in 10% fecal suspension for adequate TOPV protection against reinfection. Serum neutralizing antibody titers against poliovirus type 3 were 1:6 and 1:8 for the shorter periods of 16 and 13 days, respectively, and 1:60 and 1:45 for 36 days in multiplication of poliovirus type 3 after the second vaccination. For double infection of poliovirus types 1 and 2, only the higher titers were obtained. These results suggest that poliovirus multiplication induces the sIgA antibody in the human intestine and the induced sIgA antibody defends the subject from poliovirus infection, and that the duration and the amount of virus multiplication tend to correlate with the levels of the serum neutralizing antibody titers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11806137     DOI: 10.11150/kansenshogakuzasshi1970.75.1030

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  4 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine.

Authors:  Sidhartha Giri; Nirmal Kumar; Pavithra Dhanapal; Jayalakshmi Venkatesan; Anand Kasirajan; Miren Iturriza-Gomara; Jacob John; Asha Mary Abraham; Nicholas C Grassly; Gagandeep Kang
Journal:  J Infect Dis       Date:  2018-04-11       Impact factor: 5.226

3.  Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.

Authors:  Thomas Foiadelli; Salvatore Savasta; Andrea Battistone; Majlinda Kota; Carolina Passera; Stefano Fiore; Silvia Bino; Concetta Amato; Alessandro Lozza; Gian Luigi Marseglia; Lucia Fiore
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

Review 4.  Mucosal immunity to poliovirus.

Authors:  Ruth I Connor; Elizabeth B Brickley; Wendy F Wieland-Alter; Margaret E Ackerman; Joshua A Weiner; John F Modlin; Ananda S Bandyopadhyay; Peter F Wright
Journal:  Mucosal Immunol       Date:  2021-07-08       Impact factor: 7.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.